[go: up one dir, main page]

EP1162887A4 - Transfert de genes par virus adeno-associe recombine influant sur la demyelinisation - Google Patents

Transfert de genes par virus adeno-associe recombine influant sur la demyelinisation

Info

Publication number
EP1162887A4
EP1162887A4 EP00914979A EP00914979A EP1162887A4 EP 1162887 A4 EP1162887 A4 EP 1162887A4 EP 00914979 A EP00914979 A EP 00914979A EP 00914979 A EP00914979 A EP 00914979A EP 1162887 A4 EP1162887 A4 EP 1162887A4
Authority
EP
European Patent Office
Prior art keywords
demyelination
associated virus
recombinant adeno
genes affecting
virus transfer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00914979A
Other languages
German (de)
English (en)
Other versions
EP1162887A1 (fr
Inventor
John Guy
Xiaoping Qi
William W Hauswirth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1162887A1 publication Critical patent/EP1162887A1/fr
Publication of EP1162887A4 publication Critical patent/EP1162887A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP00914979A 1999-03-15 2000-03-15 Transfert de genes par virus adeno-associe recombine influant sur la demyelinisation Withdrawn EP1162887A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12439899P 1999-03-15 1999-03-15
US124398P 1999-03-15
PCT/US2000/006839 WO2000054595A1 (fr) 1999-03-15 2000-03-15 Transfert de genes par virus adeno-associe recombine influant sur la demyelinisation

Publications (2)

Publication Number Publication Date
EP1162887A1 EP1162887A1 (fr) 2001-12-19
EP1162887A4 true EP1162887A4 (fr) 2003-06-25

Family

ID=22414629

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00914979A Withdrawn EP1162887A4 (fr) 1999-03-15 2000-03-15 Transfert de genes par virus adeno-associe recombine influant sur la demyelinisation

Country Status (4)

Country Link
EP (1) EP1162887A4 (fr)
AU (1) AU3629200A (fr)
CA (1) CA2367648A1 (fr)
WO (1) WO2000054595A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2268741C1 (ru) * 2004-08-04 2006-01-27 Государственное образовательное учреждение высшего профессионального образования "Южно-Уральский государственный университет" Способ лечения герпетического поражения вестибулярного, спирального, тригеминального и коленчатого ганглиев
WO2008065429A1 (fr) * 2006-11-30 2008-06-05 Ucl Business Plc Procédé d'administration de vecteurs de thérapie génique à la papille optique
WO2014124142A2 (fr) 2013-02-07 2014-08-14 The Cleveland Clinic Foundation Méthodes de traitement d'un traumatisme médullaire
JP6317440B2 (ja) 2013-10-29 2018-04-25 プレジデント アンド フェローズ オブ ハーバード カレッジ 酸化ストレスを阻害するための方法および組成物
RU2649814C1 (ru) * 2017-02-14 2018-04-04 Общество с ограниченной ответственностью "Медсервис" Средство для лечения состояний человеческого организма, связанных с уменьшением уровня экспрессии гена сат и/или уменьшением активности белка каталазы на основе генно-терапевтических субстанций с геном сат, способ получения и использования

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995028493A1 (fr) * 1994-04-13 1995-10-26 The Rockefeller University Transmission par virus adenoassocie d'adn a des cellules du systeme nerveux
WO1995034670A2 (fr) * 1994-06-06 1995-12-21 Children's Hospital, Inc. Genome du virus adeno-associe recombine codant une proteine du virus de l'immunodeficience

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995028493A1 (fr) * 1994-04-13 1995-10-26 The Rockefeller University Transmission par virus adenoassocie d'adn a des cellules du systeme nerveux
WO1995034670A2 (fr) * 1994-06-06 1995-12-21 Children's Hospital, Inc. Genome du virus adeno-associe recombine codant une proteine du virus de l'immunodeficience

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
GUY J ET AL: "rAAV mediated gene transfer of catalase suppresses optic neuritis in transgenic ECSOD mice sensitized for experimental allergic encephalomyelitis (EAE).", IOVS, vol. 40, no. 4, 15 March 1999 (1999-03-15), Annual Meeting of the Association for Research in Vision and Ophthalmology;Fort Lauderdale, Florida, USA; May 9-14, 1999, pages S446, XP009001280 *
GUY J ET AL: "Viral mediated gene transfer of MnSOD suppresses, while Cu/Zn SOD exacerbates experimental optic neuritis.", IOVS, vol. 41, no. 4, 15 March 2000 (2000-03-15), Annual Meeting of the Association for Research in Vision and Ophthalmology.;Fort Lauderdale, Florida, USA; April 30-May 05, 2000, pages S129, XP001119816 *
QI XIAOPING ET AL: "Increase of manganese superoxide dismutase, but not of Cu/Zn-SOD, in experimental optic neuritis.", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 38, no. 6, 1997, pages 1203 - 1212, XP009001342, ISSN: 0146-0404 *
ROSEN D R ET AL: "Mutations in copper-zinc superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, vol. 362, no. 6415, 1993, pages 59 - 62, XP002204594, ISSN: 0028-0836 *
ROWLAND L P: "Amyotrophic lateral sclerosis: human challenge for neuroscience.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. UNITED STATES 28 FEB 1995, vol. 92, no. 5, 28 February 1995 (1995-02-28), pages 1251 - 1253, XP002237399, ISSN: 0027-8424 *
See also references of WO0054595A1 *
VAN DER VEEN ROEL C ET AL: "Contrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids.", JOURNAL OF NEUROIMMUNOLOGY, vol. 95, no. 1-2, 1 March 1999 (1999-03-01), pages 1 - 7, XP001120096, ISSN: 0165-5728 *

Also Published As

Publication number Publication date
WO2000054595A1 (fr) 2000-09-21
EP1162887A1 (fr) 2001-12-19
AU3629200A (en) 2000-10-04
CA2367648A1 (fr) 2000-09-21

Similar Documents

Publication Publication Date Title
AP2001002301A0 (en) Inhibition of viral infection using monovalentantigen-binding proteins
HUP0103908A3 (en) Novel infulenza virus vaccine composition
IL145538A0 (en) Regulation of viral gene expression
AU1775901A (en) Recombinant adeno-associated virus virions for the treatment of lysosomal disorders
GB2337755B (en) Virus vaccine
AU3635899A (en) Recombinant adenovirus gene transfer vector
EP1199908A4 (fr) Plaque chauffante en ceramique
AU3808700A (en) Compositions and methods for recombinant adeno-associated virus production
AU7077898A (en) Recombinant vectors derived from adeno-associated virus suitable for gene therapy
HUP0104046A3 (en) Adenovirus-mediated gene therapy
GB9929464D0 (en) Complementary peptide ligande generated from the human genome
AP2002002508A0 (en) The genome of the hiv-1 inter-subtype (d/b') and use thereof
EP1162887A4 (fr) Transfert de genes par virus adeno-associe recombine influant sur la demyelinisation
PL356640A1 (en) Treatment of viral infections using levovirintm
EP1175228A4 (fr) Therapie genique reposant sur l'utilisation du tgf-beta
AUPQ233799A0 (en) Recombinant sub-unit vaccine
IL148805A0 (en) Gene transfer vectors
PL364797A1 (en) Hepatitis virus sentinel virus i (svi)
HUP0201660A2 (en) Novel polypeptide and dna thereof
PL346859A1 (en) Recombinant celo virus and celo virus dna
HUP0003595A3 (en) Cyclone refractory system
EP1215284A4 (fr) Gene de type tsg
GB9702990D0 (en) Virus vaccine
GB9813670D0 (en) Preparation of recombinant adenovirus carrying a rep gene of adeno-associated virus
GB2356524B (en) Association of target groups with policy groups

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20030509

17Q First examination report despatched

Effective date: 20041110

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061003